HUMAN PAPILLOMA VIRUS VACCINE
on
Authors:
Nyoman Bayu Mahendra
Abstract:
“Cervical cancer is the most common gynecologic cancer in womer, and it has the highest cancer-related deaths in developing country. The incidences kept increasing every year, associated with delay on diagnosis, limited human resources, knowledge, education, facilities, and influence of socioeconomicculture. Currently, infection of oncogenic group high risk human papillomavirus (HPV), especially HPV-16 and HPV-18 has been widely accepted as the cause of cervical cancer. The finding of HPV vaccine brings new hope to all of us. With primary prevention, the incidence can be brought down. Later on, every women can be freed from in cervical cancer”
Keywords
Keyword Not Available
Downloads:
Download data is not yet available.
References
References Not Available
PDF:
https://jurnal.harianregional.com/medicina/full-5062
Published
2021-11-09
How To Cite
BAYU MAHENDRA, Nyoman. HUMAN PAPILLOMA VIRUS VACCINE.Medicina, [S.l.], v. 43, n. 2, apr. 2013. ISSN 2540-8321. Available at: https://jurnal.harianregional.com/medicina/id-5062. Date accessed: 28 Aug. 2025.
Citation Format
ABNT, APA, BibTeX, CBE, EndNote - EndNote format (Macintosh & Windows), MLA, ProCite - RIS format (Macintosh & Windows), RefWorks, Reference Manager - RIS format (Windows only), Turabian
Issue
Vol 43 No 2 (2012): Mei 2012
Section
Articles
Copyright
This work is licensed under a Creative Commons Attribution 4.0 International License
Discussion and feedback